The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study

The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study

Abstract Background We evaluated the efficacy of fremanezumab, a fully humanized monoclonal antibody that selectively targets calcitonin gene-related peptide, in patients with chronic migraine (CM) with and without medication overuse (MO). Methods In a 12-week, phase 3 trial, patients with CM were r...

Full description

Bibliographic Details
Main Authors: Stephen D. Silberstein, Joshua M. Cohen, Michael J. Seminerio, Ronghua Yang, Sait Ashina, Zaza Katsarava
Format: Article
Language:English
Published: BMC 2020-09-01
Series:The Journal of Headache and Pain
Subjects:
Fremanezumab
Chronic migraine
Medication overuse
Online Access:http://link.springer.com/article/10.1186/s10194-020-01173-8

Internet

http://link.springer.com/article/10.1186/s10194-020-01173-8

Similar Items